Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Abivax
Abivax
(ABVX)
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Benzocaine
carcinoma
,
kidney transplantation
,
graft rejection
,
lung diseases
,
interstitial lung diseases
,
immunologic deficiency syndromes
,
common variable immunodeficiency
,
organ transplantation
,
non-small-cell lung carcinoma
,
lung neoplasms
,
hiv infections
,
mitochondrial diseases
,
renal cell carcinoma
Obefazimod
healthy volunteers/patients
,
hiv infections
,
rheumatoid arthritis
,
arthritis
,
infections
,
acquired immunodeficiency syndrome
,
ulcerative colitis
,
colitis
,
ulcer
,
crohn disease
,
covid-19
,
respiratory insufficiency
,
inflammation
Alfacalcidol
thalassemia
,
iron overload
,
hiv infections
,
glaucoma
,
low tension glaucoma
Bos taurus adrenal cortex corticosteroids
prostatic neoplasms
,
neoplasm metastasis
,
colorectal neoplasms
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
chronic renal insufficiency
,
kidney diseases
,
type 2 diabetes mellitus
,
diabetes mellitus
,
atopic dermatitis
,
dermatitis
Fendrix
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
chronic hepatitis
,
hepatitis a
ABX-196
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use